The use of the NMDAr2B subunit-specific receptor antagonist ifenprodil produced greater reductions in EPSP durations in A1 neurons from gerbils with SNHL, suggesting increases in NMDAr2B contributions to the EPSP. This evidence concerns the gene GRIN2B and sensorineural hearing loss disorder.